MedPath

Amphetamine Cocaine Interaction Study - 2

Phase 1
Terminated
Conditions
Cocaine-Related Disorders
Registration Number
NCT00000305
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Texas Health Science Center

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

University of Texas Health Science Center
πŸ‡ΊπŸ‡ΈHouston, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.